Microparticles in Health and Disease

被引:70
作者
Enjeti, Anoop K. [1 ]
Lincz, Lisa F. [1 ]
Seldon, Michael [1 ]
机构
[1] Calvary Mater Hosp, Dept Haematol Level 4, Hunter Haematol Res Grp, Waratah Newcastle, NSW 2298, Australia
关键词
Microparticles; flow cytometry; disease; limitations; methods;
D O I
10.1055/s-0028-1104547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microparticles (NIPS) are small fragments of membrane-bound cytoplasm that are shed from the surface of an activated or apoptotic cell. Recently, their function as vectors of transcellular exchange of biologic information, in addition to better described forms of intercellular communication such as growth factors, cytokines, and chemokines, has become swell recognized. Circulating levels of MPs are thought to reflect a balance between cell stimulation, proliferation, and death. The production of NIPS is thought to predominately occur by vesiculation or blebbing of the cell membrane. The mechanisms governing the remodeling of the plasma membrane are complex, involving cytoskeletal changes and a shift from normal phospholipid asymmetry. Increased intracellular calcium subsequent to cell activation leads to intracellular increases in several proteins including gelsolin and calpain, as well as the activity of enzymes such as translocase, floppase, and scramblase, which play important roles in the homeostasis of the cell membrane. The membrane vesiculation,and phospholipids asytmmetry leading to the production of MPs occurs by the complex interplay of the proteins. involved. There are several clinical conditions associated with elevated MPs, and most are also associated with an increased risk of thrombosis. Apart from cardiovascular disease and venous thromboembolism, MPs are also elevated in solid tumors with metastatic disease. The measurement of NIPS is being regarded as a potential biomarker, given the range of conditions in which they are elevated sand the association with prothrombotic states. The utility of measuring MPs as a diagnostic and prognostic marker is currently a subject of intense investigation. The further development of the various methods for the detection and measurement of NIPS and prospective clinical trials establishing the utility of such tests will be critical prior to the routine measurement of MPs in the diagnostic laboratory.
引用
收藏
页码:683 / 691
页数:9
相关论文
共 90 条
[1]   Cell-derived microparticles: 'Miniature envoys with many faces' [J].
Ahn, YS .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (05) :884-887
[2]  
Andres E, 2007, Haematologica, V92, pe65, DOI 10.3324/haematol.11480
[3]  
ANDRES E, 2007, HAEMATOLOGICA, V92, pE65
[4]   The role of microparticles in inflammation and thrombosis [J].
Ardoin, S. P. ;
Shanahan, J. C. ;
Pisetsky, D. S. .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 66 (2-3) :159-165
[5]   Modulation of monocyte-endothelial cell interactions by platelet microparticles [J].
Barry, OP ;
Praticò, D ;
Savani, RC ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :136-144
[6]   Thanatosomes and cardiomyocyte apoptotic bodies [J].
Beranek, JT .
HUMAN PATHOLOGY, 2001, 32 (08) :894-894
[7]   Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia [J].
Bidot, CJ ;
Jy, W ;
Horstman, LL ;
Ahn, ER ;
Bidot, L ;
Fontana, V ;
Ahn, YS .
HEMATOLOGY, 2005, 10 (06) :451-456
[8]   Haemostatic changes in pregnancy [J].
Brenner, B .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :409-414
[9]   Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis [J].
Brisset, AC ;
Terrisse, AD ;
Dupouy, D ;
Tellier, L ;
Pech, S ;
Navarro, C ;
Sié, P .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (03) :511-518
[10]   Hematogenous micrometastases in osteosarcoma patients [J].
Bruland, OS ;
Hoifodt, H ;
Sæter, G ;
Smeland, S ;
Fodstad, O .
CLINICAL CANCER RESEARCH, 2005, 11 (13) :4666-4673